Bayer Reaches a Series of Agreements

Bayer announces agreements to resolve major legacy Monsanto litigation

Company will make a total payment of $10.1 billion to $10.9 billion (€9.1 billion to €9.8 billion) to resolve current and address potential future Roundup™ litigation/ • Company also resolves dicamba drift litigation for payment of up to $400 million and most PCB water litigation exposure for payment of approximately $820 million/ • Funding sourced from free cash flow and Animal Health divestment /• Bayer is well positioned to deliver science-based solutions to meet global health, nutrition needs Read more

Non-metastatic castration resistant prostate cancer treatment NUBEQA® (darolutamide) significantly improves overall survival with a favourable safety profile in men with non-metastatic prostate cancer

Read more

Bayer partners with Population Health Research Institute (PHRI) on major global research study on COVID-19 treatments

Read more

Bayer announces agreements to resolve major legacy Monsanto litigation

Read more